Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
Condition(s):LymphangioleiomyomatosisLast Updated:August 26, 2015Completed
Hide Studies Not Open or Pending
Condition(s):LymphangioleiomyomatosisLast Updated:August 26, 2015Completed
Condition(s):LymphangioleiomyomatosisLast Updated:November 19, 2020Completed
Condition(s):LymphangioleiomyomatosisLast Updated:November 2, 2023Completed
Condition(s):LeiomyomatosisLast Updated:March 4, 2008Completed
Condition(s):Tuberous Sclerosis Complex; LymphangioleiomyomatosisLast Updated:December 7, 2023Recruiting
Condition(s):Chronic Respiratory Diseases; Cystic Fibrosis; Lymphangioleiomyomatosis; Hypersensitivity Pneumonitis; Interstitial Lung Diseases; COPD; Bronchial AsthmaLast Updated:February 14, 2023Enrolling by invitation
Condition(s):Tuberous Sclerosis; LymphangioleiomyomatosisLast Updated:February 9, 2024Recruiting
Condition(s):Lymphangioleiomyomatosis; Tuberous Sclerosis ComplexLast Updated:August 1, 2023Recruiting
Condition(s):Lymphangioleiomyomatosis; Tuberous Sclerosis ComplexLast Updated:March 29, 2023Completed
Condition(s):Lymphangioleiomyomatosis; Sleep Disorder; Sleep Apnea Syndromes; Hypopnea SyndromeLast Updated:March 18, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.